http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103193976-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1af37e2583cac38bf75ec1b20ba29616
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
filingDate 2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a73359cae60a7a0e94a49115c4a9efdf
publicationDate 2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103193976-A
titleOfInvention Synthesis and application of a kind of cardiolipin
abstract The invention provides a novel PEG-modified cardiolipin and its synthesis. The novel cardiolipin can be used to prepare liposomes, which can also contain active agents, such as hydrophobic or hydrophilic drugs. Such liposomes may be used in the treatment of diseases or in diagnostic and/or analytical assays. Liposomes can also contain ligands for targeting to specific cell types or specific tissues.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106124783-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106124783-B
priorityDate 2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006004935-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466368877

Total number of triples: 17.